Treatment of rats during pubertal development with 2,3,7,8-tetrachlorodibenzo-p-dioxin alters both signaling kinase activities and epidermal growth factor receptor binding in the testis and the motility and acrosomal reaction of sperm

Toxicology and Applied Pharmacology

Volumn 150, Issue 2, 1998, Pages 427-442

  El Sabeawy, Faten ^a   Wang, Shuyi ^a   Overstreet, James ^a   Miller, Marion ^a   Lasley, Bill ^a   Enan, Essam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C;

ACROSOME REACTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FOOD INTAKE; HISTOPATHOLOGY; MALE; NONHUMAN; ONCOGENE SRC; PUBERTY; RAT; REPRODUCTIVE TOXICITY; SEMEN ANALYSIS; SEMINIFEROUS TUBULE; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TESTIS; TESTIS ATROPHY; TESTIS DEVELOPMENT;

ANIMALIA; ZEA MAYS;

EID: 0032102432     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8426     Document Type: Article

References (98)

1. Bjerk D. L., Peterson R. E. Reproductive toxicity of 2,3,7,8-tetrachlorodibenzo-pin utero. Toxicol. Appl. Pharmacol. 127:1994;241-249.
2. Bjerke D. L., Sommer R. J., Moore R. W., Peterson R. E. Effects ofin uterop. Toxicol. Appl. Pharmacol. 127:1994;250-257.
3. Blazak W. F., Treinen K. A., Juniewicz P. E. Application of testicular sperm head counts in the assessment of male reproductive toxicity. Methods Toxicol. 3A:1993;86-94.
4. Blumer K. J., Johnson G. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19:1994;236-240.
5. Bookstaff R. C., Kamel F., Moore R. W., Bjerke D. L., Peterson R. E. Altered regulation of pituitary responsiveness to GnRH in 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 105:1990a;78-92.
6. Bookstaff R. C., Moore R. W., Peterson R. E. 2,3,7,8-Tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 104:1990b;212-224.
7. Bossert N. L., Nelson K. G., Ross K. A., Takahashi T., McLachlan J. A. Epidermal growth factor binding and receptor distribution in the mouse reproductive tract during development. Dev. Biol. 142:1990;75-85.
8. Boyce B. F., Chen H., Soriano P., Mundy G. R. Histomorphometric and immunocytochemical studies of src-related osteopetrosis. Bone. 14:1993;335-340.
9. Brickell P. M. The P60c-src family of protein-tyrosine kinases: Structure, regulation, and function. Crit. Rev. Oncol. 3:1992;401-446.
10. Carlson E., Giwercman A., Keiding N., Skakkebaek N. E. Evidence for decreasing quality of semen during past 50 years. Br. Med. J. 305:1992;609-613.
11. Chaffin C. L., Peterson R. E., Hutz R. J. In uterop. Biol. Reprod. 55:1996;62-67.
12. Colburn T., Vom Saal F. S., Soto A. M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101:1993;378-384.
13. Crews C. M., Alessandrini A., Erickson R. L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science Wash. 258:1992;478.
14. Cunha G. R., Alarid E. T., Turner T., Donjacour A. A., Boutin E. L., Foster B. A. Normal and abnormal development of the male urogenital tract: Role of androgens, mesenchymal-epithelial interactions and growth factors. J. Androl. 13:1992;465-475.
15. r. Biochem. Biophys. Res. Commun. 155:1988b;801-807.
16. Denison M. S., Fisher J. M., Whitlock J. P. Jr. The DNA recognition site for the dioxin-Ah receptor complex: Nucleotide sequence and functional analysis. J. Biol. Chem. 263:1988a;17221-17224.
17. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res. 11:1983;1475-1489.
18. Enan E., Matsumura F. Activation of phosphoinositide/protein kinase C pathway in rat brain tissue by pyrethroids. Biochem. Pharmacol. 45:1992;703-710.
19. Enan E., Matsumura F. 2,3,7,8-tetrachlorodibenzo-p. J. Biochem. Toxicol. 8:1993;89-99.
20. Enan E., Matsumura F. Significance of TCDD-induced in protein phosphorylation in the adipocyte of male guinea pigs. J. Biochem. Toxicol. 9:1994a;159-170.
21. Enan E., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-pin vivoin vitro. J. Biochem. Toxicol. 9:1994b;97-106.
22. Enan E., Matsumura F. Evidence for a second pathway in the action mechanism of TCDD: Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49:1995a;249-261.
23. Enan E., Matsumura F. Regulation of AP-1 activity by TCDD through nuclear protein phosphorylation in adipose tissue of guinea pig. Biochem. Pharmacol. 50:1995b;1199-1206.
24. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p. Biochem. Pharmacol. 52:1996;1599-1612.
25. Enan E., El-Sabeawy F., Moran F., Overstreet J., Lasley B. TCDD interrupts estradiol signal transduction through the protein phosphorylation pathway in adipose tissues from immature and mature female rats. Biochem. Pharmacol. 1998a.
26. Enan E., El-Sabeawy F., Overstreet J., Lasley B. Mechanism of gender-specific TCDD-induced toxicity to guinea pig adipose tissues. Reprod. Toxicol. 1998b.
27. Enan E., Lasley, Stweart D., Overstreet J., Van de Voort C. 2,3,7,8-Tetrachlorodibenzo-p. Reprod. Toxicol. 10:1996b;191-198.
28. Enan E., Moran F., VandeVoort C., Overstreet J., Stewart D., Lasley B. Mechanism of 2,3,7,8-tetrachlorodibenzo-p. Reprod. Toxicol. 10:1996a;1599-1612.
29. Enan E., Overstreet J., Matsumura F., Lasley B. Gender differences in the mechanism of dioxin toxicity in rodents and in nonhuman primates. Reprod. Toxicol. 10:1996c;401-411.
30. Fisch H., Ikeguchi E. F., Goluboff E. T. Worldwide variations in sperm counts. Urology. 48:1996;909-911.
31. Flores A. L. C., Kinkead T., Carboni A. A., Menon M., Seethalakshmi L. Effects of sialoadenectomy and epidermal growth factor on testicular function of sexually mature male mice. J. Urol. 152:1994;554-561.
32. Guillette L. J. Jr., Crain D. A., Rooney A. A., Pickford D. B. Organization versus activation: The role of endocrine-disrupting contaminants (EDCs) during embryonic development in wildlife. Environ. Health Perspect. 103:1995a;157-164.
33. Guillette L. J. Jr., Gross T. S., Gross D. A., Rooney A. A., Percival H. F. Gonadal steroidogenesisin vitro. Environ. Health Perspect. 103:1995b;31-36.
34. Gupta C. The role of epidermal growth fatcor receptor (EGFR) in male reproductive tract differentiation: Stimulation of EGFR expression and inhibition of Wolffin duct differentiation with anti-EGFR antibody. Endocrinology. 137:1996;905-910.
35. Gupta C., Siegel S., Ellis D. The role of EGF in testosterone-induced reproductive tract differentiation. Dev. Biol. 146:1991;106-116.
36. Herschman H. R. Primary response genes induced by growth factors and tumor promotors. Annu. Rev. Biochem. 60:1991;281-319.
37. Holt W. V., Palomo M. J. Optimization of a continuous real-time computerized semen analysis system for ram sperm motility assessment, and evaluation of four methods of semen preparation. Reprod. Fertil. Dev. 8:1996;219-230.
38. Hunter T., Ling N., Cooper J. A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature. 311:1984;480-483.
39. Ikonen T., Palvimo J. J., Kallio P. J., Reinikainen, Janne O. A. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology. 135:1994;1359-1366.
40. Jensen T. K., Toppari J., Keiding N., Skakkebaek E. Do environmental estrogens contribute to the decline in male reproductive health. Clin. Chem. 41:1995;1896-1901.
41. Johnson L., Dickerson R., Safe S., Nyberg C., Lewis R., Welsh T. H. Jr. Reduced Leydig cell volume and function in adult rats to 2,3,7,8-tetrachlorodibenzo-p. Toxicology. 76:1992;103-118.
42. Johnson L., Wilker C. E., Safe S. H., Scott B., Dean D. D., White P. H. 2,3,7,8-Tetrachlorodibenzo-p. Toxicology. 89:1994;49-65.
43. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science (Washington, D.C.). 270:1995;1491-1494.
44. Kemppainen J. A., Lane M. V., Sar M., Wilson E. M. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 267:1992;968-974.
45. Kleeman J. M., Moore R. W., Peterson R. E. Inhibition of testicular steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 106:1990;112-115.
46. Klinefelter G. R., Gray L. E. Jr., Suarez J. D. The method of sperm collection significantly influences sperm motion parameters following ethane dimethanesulphonate administration in the rat. Reprod. Toxicol. 5:1991;39-44.
47. Koch C. A., Anderson D., Moran M. F., Ellis C., Pawson T. SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science (Washington, D.C.). 252:1991;668-674.
48. Kuiper G. G., Brinkmann A. O. Phosphotryptic peptide analysis of the human androgen receptor: Detection of a hormone-induced phosphopeptide. Biochemistry. 34:1995;1851-1857.
49. Kuiper G. G., de Ruiter P. E., Trapman J., Boersma W. J., Grootegoed J. A., Brinkmann A. O. Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochem. J. 291:1993;95-101.
50. Kyriakis J. M., App H., Zhang X.-F., Banerjee P., Brautigan D. L., Rapp U. R., Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 358:1992;417-421.
51. Loveland K. L., Hedger M. P., Risbridger G., Herszfeld D., Kertser D. M. Identification of receptor tyrosine kinases in the rat testis. Mol. Reprod. Dev. 36:1993;440-447.
52. Maa M. C., Leu T. H., McCarley D. J., Schatzman R. C., Parsons S. J. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. USA. 92:1995;6981-6985.
53. Mably T. A., Bjerke D. L., Moore R. W., Gendron-Fitzpatrick A., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 114:1992a;118-126.
54. Mably T. A., Moore R. W., Bjerke D. L., Peterson R. E. The male reproductive system is highly sensitive to in utero and lactational 2,3,7,8-tetrachlorodibenzo-p. Banbury Report No. 35: Biological Basis for Risk Assessments of Dioxins and Related Compounds. 1991;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 69.
55. Mably T. A., Moore R. W., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 114:1992b;97-107.
56. Matsumura F., Brewster D. W., Madhukar B. V., Bombick D. W. Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p. Arch. Environ. Contam. Toxicol. 13:1984;509-515.
57. Matsumura, F. Madhukar, B. V. Bombick, D. W. Brewster, D. W. 1985, Toxicological significance of pleiotropic changes of plasma membrane functions particularly that of EGF receptor caused by 2,3,7,8-TCDD, Banbury Report 18: Biological Mechanisms of Dioxin Action, 267, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. McConnell E. E., Moore J. A., Haseman J. K., Harris M. W. The comparative toxicity of chlorinated dibenzo-p. Toxicol. Appl. Pharmacol. 44:1978;335-356.
59. Mebus C. A., Reddy V. R., Piper W. N. Depression of rat testicular 17-hydroxylase and 17,20-lyase after administration of 2,3,7,8-tetrachlorodibenzo-p. Biochem. Pharmacol. 36:1987;727-731.
60. Meek D. W., Street A. J. Nuclear protein phosphorylation and growth control. Biochem. J. 287:1992;1-15.
61. Misrahi M., Loosfelt H., Atger M., Sar S., Guiochon-Mantel A., Milgrom E. Cloning, sequencing and expression of human TSH receptor. Biochem. Biophys. Res. Commun. 166:1990;394-403.
62. Moore R. W., Jefcoate C. R., Peterson R. E. 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 109:1991;85-97.
63. Moore R. W., Mably T. A., Peterson R. E. Effects of perinatal 2,3,7,8-tetrachlorodibenzo-p. Toxicologist. 10:1990;247.
64. Moore R. W., Parsons J. A., Bookstaff R. C., Peterson R. E. Plasma concentrations of pituitary hormones in 2,3,7,8-tetrachlorodibenzo-p. J. Biochem. Toxicol. 4:1989;165-172.
65. Moore R. W., Potter C. L., Theobald H. M., Robinson J. A., Peterson R. E. Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 79:1985;99-111.
66. Morrissey R. E., Schwetz B. A. Reproductive and developmental toxicity in animals. Kimbrough R. D., Jensen A. A. Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products. 1989;195-225 Elsevier, New York.
67. Olsen G. W., Bodner K. M., Ramlow J. M. Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited. Fertil. Steril. 63:1995;887-893.
68. Peterson R. E., Theobald H. M., Kimmel G. L. Developmental and reproductive toxicity of dioxins and related compounds: Cross-species comparisons. Crit. Rev. Toxicol. 23:1993;283-335.
69. Poland A., Kende A. The genetic expression of aryl hydrocarbon hydroxylase activity: Evidence for a receptor mutation in nonresponsive mice. Hiatt H. H., Watson S. D. Origins of Human Cancer. 1977;847 Cold Spring Harbor Laboratory, Cold Spring Harbor.
70. Poland A., Kimbrough R. D. Banbury Report 18: Biological Mechanisms of Dioxin Action. 1984;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 1-500.
71. Poland A., Knutson J. C. 2,3,7,8-Tetrachlorodibenzo-p. Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
72. Poland A., Glover E., Kende A. S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p. J. Biol. Chem. 251:1976;4936-4946.
73. Privalsky M. L. A subpopulation of the v-erb A oncogene protein, a derivative of a thyroid hormone receptor, associates with heat shock protein 90. J. Biol. Chem. 266:1991;1456-1462.
74. Reeves S. A., Sinha B., Bauer I., Reinhold D., Harsh G. An alternative role for the src-homology-domain-containing phosphotyrosine phosphatase (SH-PTP2) in regulating epidermal-growth-factor-dependent cell growth. Eur. J. Biochem. 233:1995;55-61.
75. Reyes H., Reisz-Porszasz S., Hankinson O. Identification of the Ah receptor nuclear translocator protein (arnt) as a component of the DNA binding from of the Ah receptor. Science (Washington, D.C.). 256:1992;1193-1195.
76. c-srcis a positive regulator of growth factor-induced cell scattering in a rat bladder carcinoma cell line. J. Cell Biol. 131:1995;761-773.
77. Rodriguez M., Berman J., Gilmer T. M. Involvement of pp60c-src. Proc. Natl. Acad. Sci. USA. 91:1994;83-87.
78. Salzberger Z., Lewin L. M., Shalgi R. Loss of acid phosphatase from rat spermatozoa as a method for assessing the acrosome reaction. Andrologia. 24:1992;155-159.
79. Sevetson B. R., Kong X., Lawrence J. C. Jr. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;10305-10309.
80. Skakkebaek E., Keiding N. Changes in semen and the testis. Br. Med. J. 309:1994;1316-1317.
81. Sommer R. J., Ippolito D. L., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 140:1996;146-153.
82. Stone R. Environmental estrogens stir debate. Science (Washington, D.C.). 265:1994;308-310.
83. 85. J. Biol. Chem. 270:1995;15591-15597.
84. Sun X. J., Wang L. M., Zhang Y., Yenush L., Myers M. G. Jr., Glasheen E., Lane W. S., Pierce J. H., White M. F. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:1995;173-177.
85. Swan S. H., Elkin E. P., Fenster L. Have sperm densities declined? A reanalysis of global trend data. Environ. Health Perspect. 105:1997;1228-1232.
86. Taylor S. J., Shalloway D. The cell cycle and c-Src. Curr. Opin. Genet. Dev. 3:1993;26-34.
87. Theobald H. M., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 145:1997;124-135.
88. Timme T. L., Truong L. D., Merz V. W., Krebs T., Kadmon D., Flanders K. C., Park S. H., Thompson T. C. Mesenchymal-epithelial interactions and transforming growth factor-B expression during mouse prostate morphogenesis. Endocrinology. 134:1994;1039-1045.
89. Traish A. M., Wotiz H. H. Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology. 121:1987;1461-1467.
90. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
91. Vos J. G., Moore J. A., Zinkl J. G. Toxicity of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 29:1974;229-241.
92. Whitelaw M., Pongratz I., Wilhelmsson A., Gustafsson J. A., Poellinger L. Ligand-dependent recruitment of the arnt coregulator determines DNA recognition by the dioxin receptor. Mol. Cell. Biol. 13:1993;2504-2514.
93. v-src. J. Biol. Chem. 266:1991;16436-16440.
94. v-src. Proc. Natl. Acad. Sci. USA. 91:1994;8324-8328.
95. Whitlock J. P. Jr. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p. Annu. Rev. Pharmacol. Toxicol. 30:1990;251-277.
96. Wilker C. E., Welsh T. H. Jr., Safe S. H., Narasimhan T. R., Johnson L. Human chorionic gonadotropin protects Leydig cell function against 2,3,7,8-Tetrachlorodibenzo-p. Toxicology. 95:1995;93-102.
97. Yamaki H., Nakajima M., Seimiyah, Saya H., Sugita M., Tsuruo T. Inhibition of the association, with nuclear matrix of pRB, p70 and p40 proteins along with the specific suppression of c-MYC expression by geldanamycin, an inhibitor of Src tyrosine kinase. J. Antibiot. 48:1995;1021-1026.
98. Yanagimachi R. Mammalian fertilization. Knobil E., Neil J. D. The Physiology of Reproduction. 1994;189-317 Raven Press, New York.